Craniomaxillofacial (CMF)
The markets for craniomaxillofacial (CMF) devices and the biologics used in CMF and neurosurgical procedures including: plates and screws, bone graft substitutes, cranial flap fixation, dural repair and temporomandibular joint (TMJ) as well as products used in thoracic surgery for sternal closure as many manufacturers often group these products within their CMF portfolio.
Showing all 9 results
Orthobiologics Market Analysis, Size, Trends | China | 2020-2026 | MedSuite
In 2020, the Chinese orthobiologics market size was valued at $460.7 million, with over 424,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 6% to reach $690.8 million in 2026. Throughout this medical market research, we analyzed 28 orthobiologics companies across China
more...Orthobiologics Market Analysis, Size, Trends | India | 2020-2026 | MedSuite
In 2020, the Indian orthobiologics market size was valued at $76.2 million, with over 520,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 12.4% to reach $172.3 million in 2026. Throughout this medical market research, we analyzed 23 orthobiologics companies across India
more...Orthobiologics Market Analysis, Size, Trends | Japan | 2020-2026 | MedSuite
In 2020, the Japanese orthobiologics market size was valued at $426.9 million, with over 221,000 bone grafting procedures performed every year. The market size is expected to fluctuate over the forecast period with a -0.4% compound annual growth rate (CAGR). Throughout this medical market research, we analyzed 16 orthobiologics companies across Japan and used our
more...Orthobiologics Market Analysis, Size, Trends | South Korea | 2020-2026 | MedSuite
In 2020, the South Korean orthobiologics market size was valued at $141.6 million, with over 200,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $181.5 million in 2026. Throughout this medical market research, we analyzed 16 orthobiologics companies across
more...Orthobiologics Market Analysis, Size, Trends | Australia | 2020-2026 | Medsuite
In 2020, the Australian orthobiologics market size was valued at $63.8 million, with over 29,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 4.9% to reach $89.4 million in 2026. Throughout this medical market research, we analyzed 48 orthobiologics companies across Australia
more...Orthobiologics Market Size, Share & COVID19 Impact Analysis | Europe | 2019-2025 | MedSuite | Includes: Orthopedic Bone Graft Substitutes (Allograft Bone Graft Substitute, Synthetic Bone Graft Substitute, and Demineralized Bone Graft Substitute Bone Matrix), Hyaluronic Acid Viscosupplementation, Bone Morphogenic Protein Growth Factor Therapy & Cartilage Repair (Segmented by Osteochondral Allografts, Meniscal Allografts, Autologous Chondrocyte Implantations, and Osteochondral Autografts)
The total European orthobiologics market is growing at a rate of 1.6%, which will take the 2018 market value of €521.2 million up to €582.3 million by 2025. Constraints on reimbursements will continue to limit the European orthobiologics market. Presently, only a few premium products under the umbrella of pharmaceuticals are reimbursed by the government
more...Orthobiologics Market Size, Share & COVID19 Impact Analysis | United States | 2019-2025 | MedSuite | Includes: Orthopedic Bone Graft Substitutes, Orthopedic Growth Factor, Cellular Allograft (Cervical Spine and Lumbar Spine Cellular Allografts), Orthopedic Cell Therapy (Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate), Hyaluronic Acid Viscosupplementation, Orthopedic Cartilage Repair ( Osteochondral Allograft, Meniscal Allograft, Autologous Chondrocyte Implantation, Particulated Juvenile Allograft and Microfracture Adjunct), Spinal Machined Bone Allograft (ALIF, PLIF, TLIF and CIF Machined Bone Allografts)
The total US orthobiologics market is growing at a rate of 4.9%, which will take the 2018 market value of $3.6 billion up to $5 billion by 2025. A particular trend in the U.S. orthobiologics market is competitors that are seeking to penetrate high growth segments outside their traditional space by distributing existing products manufactured
more...Orthobiologics Market Analysis, Size, Trends | Global | 2019-2025 | MedSuite
Industry Trends A particular trend in the U.S. orthobiologics market is competitors that are seeking to penetrate high growth segments outside their traditional space by distributing existing products manufactured by other companies, rather than creating their own. This often involves partnering with a company by taking on the costs associated with regulation and market approval,
more...Craniomaxillofacial and Thoracic Surgery Devices Market Report Suite | United States | 2015-2021 | MedSuite
This report covers the markets for craniomaxillofacial (CMF) devices and the biologics used in CMF and
neurosurgical procedures including: plates and screws, bone graft substitutes, cranial flap fixation, dural
repair and temporomandibular joint (TMJ). The report also includes products used in thoracic surgery for
sternal closure as many manufacturers often group these products within their CMF portfolio.